Genincode PLC
LSE:GENI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Genincode PLC
Free Cash Flow
Genincode PLC
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Genincode PLC
LSE:GENI
|
Free Cash Flow
-£5.1m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kooth PLC
LSE:KOO
|
Free Cash Flow
£1.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PHSC PLC
LSE:PHSC
|
Free Cash Flow
-£102.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
|
Iconic Labs PLC
LSE:ICON
|
Free Cash Flow
-£448.1k
|
CAGR 3-Years
-106%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trellus Health PLC
LSE:TRLS
|
Free Cash Flow
-$7.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genincode PLC
Glance View
GENinCode UK Ltd. engages in the risk assessment and prediction of cardiovascular disease. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2021-07-22. The firm develops patented deoxyribonucleic acid (DNA) risk assessment products which utilize artificial intelligence (AI), bioinformatics and a globally recognized clinical evidence base to provide predictive analysis of a patient’s health risk. The Company’s clinical diagnostic tests cover global disease areas such as cardiovascular, cancer and diabetes.
See Also
What is Genincode PLC's Free Cash Flow?
Free Cash Flow
-5.1m
GBP
Based on the financial report for Dec 31, 2024, Genincode PLC's Free Cash Flow amounts to -5.1m GBP.
What is Genincode PLC's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-17%
Over the last year, the Free Cash Flow growth was 30%. The average annual Free Cash Flow growth rates for Genincode PLC have been -17% over the past three years .